Angelica Cuapio

Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Journal: EBioMedicine

Published: November 12, 2025

Fifty Years of Natural Killer Cells: Milestones and Future Horizons.

Fifty Years of Natural Killer Cells: Milestones and Future Horizons.

Journal: Scandinavian journal of immunology

Published: November 06, 2025

Both inhibitory and activating KIRs recognize RIFINs: a dual-edged mechanism of NK cell control in malaria.

Both inhibitory and activating KIRs recognize RIFINs: a dual-edged mechanism of NK cell control in malaria.

Journal: Signal transduction and targeted therapy

Published: June 29, 2025

Inborn errors of immunity affecting the MHC class I pathway for antigen presentation.

Inborn errors of immunity affecting the MHC class I pathway for antigen presentation.

Journal: Journal of human immunity

Published: March 04, 2025

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Journal: EBioMedicine

Published: May 01, 2024

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID.

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID.

Journal: EBioMedicine

Published: April 03, 2023

NK cells in COVID-19-from disease to vaccination.

NK cells in COVID-19-from disease to vaccination.

Journal: Journal of leukocyte biology

Published: November 21, 2022

The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposes.

The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposes.

Journal: Scandinavian journal of immunology

Published: April 07, 2022

Long-COVID in children and adolescents: a systematic review and meta-analyses.

Long-COVID in children and adolescents: a systematic review and meta-analyses.

Journal: Scientific reports

Published: March 12, 2022

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 18, 2022

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 13, 2022

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.

Journal: Immunity

Published: December 16, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026